

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by virus of host process (GO:0019054) | 6.25387616 |
| 2 | modulation by symbiont of host cellular process (GO:0044068) | 5.47533772 |
| 3 | adenosine receptor signaling pathway (GO:0001973) | 5.34147426 |
| 4 | cellular response to ATP (GO:0071318) | 4.80037314 |
| 5 | GDP-mannose metabolic process (GO:0019673) | 4.79796557 |
| 6 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.63775427 |
| 7 | mannose metabolic process (GO:0006013) | 4.57117436 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.40451088 |
| 9 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.32972897 |
| 10 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.19055822 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99549384 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98539417 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.97645397 |
| 14 | tolerance induction (GO:0002507) | 3.82577478 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.82118626 |
| 16 | positive regulation of protein kinase C signaling (GO:0090037) | 3.73718762 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.72760695 |
| 18 | protein carboxylation (GO:0018214) | 3.72760695 |
| 19 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.71739166 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.62705624 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.60829369 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60829369 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60270685 |
| 24 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.59319428 |
| 25 | negative regulation of viral release from host cell (GO:1902187) | 3.56859598 |
| 26 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.44194309 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.43713928 |
| 28 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.37406816 |
| 29 | mature B cell differentiation involved in immune response (GO:0002313) | 3.36980558 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.36712854 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28439824 |
| 32 | UV protection (GO:0009650) | 3.26021877 |
| 33 | modulation by virus of host morphology or physiology (GO:0019048) | 3.24886526 |
| 34 | purinergic receptor signaling pathway (GO:0035587) | 3.24345852 |
| 35 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.22088075 |
| 36 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.16993451 |
| 37 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.15620433 |
| 38 | amyloid precursor protein catabolic process (GO:0042987) | 3.13934318 |
| 39 | regulation of skeletal muscle contraction (GO:0014819) | 3.10580043 |
| 40 | thymic T cell selection (GO:0045061) | 3.08488584 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05732726 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 3.04518718 |
| 43 | positive regulation of Rap GTPase activity (GO:0032854) | 3.03694925 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99245704 |
| 45 | response to ATP (GO:0033198) | 2.95601479 |
| 46 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.95330903 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94182989 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93318150 |
| 49 | semaphorin-plexin signaling pathway (GO:0071526) | 2.90435366 |
| 50 | regulation of ARF GTPase activity (GO:0032312) | 2.89224967 |
| 51 | regulation of translational fidelity (GO:0006450) | 2.87846382 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 2.86994188 |
| 53 | response to muramyl dipeptide (GO:0032495) | 2.86010124 |
| 54 | negative regulation of viral entry into host cell (GO:0046597) | 2.84192456 |
| 55 | adenine nucleotide transport (GO:0051503) | 2.82446373 |
| 56 | sensory perception of taste (GO:0050909) | 2.79550936 |
| 57 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.76889712 |
| 58 | regulation of viral release from host cell (GO:1902186) | 2.75617839 |
| 59 | response to peptidoglycan (GO:0032494) | 2.75469389 |
| 60 | negative regulation of cell aging (GO:0090344) | 2.71763630 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.71258099 |
| 62 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.70120968 |
| 63 | response to type I interferon (GO:0034340) | 2.68670316 |
| 64 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.68325019 |
| 65 | leukocyte aggregation (GO:0070486) | 2.67781738 |
| 66 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.65891982 |
| 67 | DNA strand renaturation (GO:0000733) | 2.64917351 |
| 68 | negative regulation of innate immune response (GO:0045824) | 2.63469238 |
| 69 | germinal center formation (GO:0002467) | 2.62864982 |
| 70 | type I interferon signaling pathway (GO:0060337) | 2.59902293 |
| 71 | cellular response to type I interferon (GO:0071357) | 2.59902293 |
| 72 | interferon-gamma production (GO:0032609) | 2.58596883 |
| 73 | positive T cell selection (GO:0043368) | 2.58509688 |
| 74 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.57316573 |
| 75 | lens fiber cell differentiation (GO:0070306) | 2.55961502 |
| 76 | cellular response to virus (GO:0098586) | 2.52714357 |
| 77 | T cell selection (GO:0045058) | 2.51681971 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 2.49928757 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.49867564 |
| 80 | defense response to protozoan (GO:0042832) | 2.49550203 |
| 81 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.49375488 |
| 82 | purine ribonucleotide transport (GO:0015868) | 2.49318104 |
| 83 | response to protozoan (GO:0001562) | 2.44342043 |
| 84 | retrograde transport, endosome to Golgi (GO:0042147) | 2.42980701 |
| 85 | mature B cell differentiation (GO:0002335) | 2.41364974 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39164208 |
| 87 | activation of JUN kinase activity (GO:0007257) | 2.38848005 |
| 88 | negative regulation of interleukin-8 production (GO:0032717) | 2.38193376 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37035984 |
| 90 | positive regulation of receptor recycling (GO:0001921) | 2.35915626 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 2.32742228 |
| 92 | regulation of Rap GTPase activity (GO:0032317) | 2.32268942 |
| 93 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.31593135 |
| 94 | protein insertion into membrane (GO:0051205) | 2.31585250 |
| 95 | regulation of ARF protein signal transduction (GO:0032012) | 2.31069783 |
| 96 | melanin biosynthetic process (GO:0042438) | 2.28557028 |
| 97 | melanin metabolic process (GO:0006582) | 2.28383473 |
| 98 | urinary tract smooth muscle contraction (GO:0014848) | 2.27669770 |
| 99 | activation of MAPKKK activity (GO:0000185) | 2.26963842 |
| 100 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.25680348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.88684912 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.33893982 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.80036054 |
| 4 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68941575 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.59155293 |
| 6 | * P68_20966046_ChIP-Seq_HELA_Human | 2.51064067 |
| 7 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.42530034 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.37177079 |
| 9 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.33694205 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.33458795 |
| 11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.30822385 |
| 12 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.28642841 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28099741 |
| 14 | MAF_26560356_Chip-Seq_TH2_Human | 2.26196361 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17695197 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.16546843 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13434242 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.10172635 |
| 19 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.04187620 |
| 20 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02875137 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.00515957 |
| 22 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.98899728 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97160985 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94253943 |
| 25 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.88403483 |
| 26 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.88120880 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.87768068 |
| 28 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.85194528 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84251402 |
| 30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.81390743 |
| 31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.80854953 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77393272 |
| 33 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.72681525 |
| 34 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.71562079 |
| 35 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.68998442 |
| 36 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.68762076 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.68340982 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68203067 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.64894638 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61166795 |
| 41 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.60309876 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59538751 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58792294 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58740237 |
| 45 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.57977048 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56327332 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49645056 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48961291 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48439533 |
| 50 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.47218697 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46520263 |
| 52 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.46436733 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44746310 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42842142 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42693034 |
| 56 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.41790430 |
| 57 | SA1_27219007_Chip-Seq_Bcells_Human | 1.40301541 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39437538 |
| 59 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.38197599 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37432478 |
| 61 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.33621469 |
| 62 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33173511 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30459471 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.28651287 |
| 65 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.27345167 |
| 66 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26803182 |
| 67 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26646466 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25856296 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25651760 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23499220 |
| 71 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.22569792 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22409962 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21962601 |
| 74 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21556510 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19915451 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19658120 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19112209 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16940415 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15398367 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15320126 |
| 81 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13777492 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13218192 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12670133 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.12378486 |
| 85 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11389525 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10820056 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10520629 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09576459 |
| 89 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09508488 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09373267 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08752270 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08708667 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08333558 |
| 94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07865271 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07227178 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05748780 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05104673 |
| 98 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04915410 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03617226 |
| 100 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.03053697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 4.54169136 |
| 2 | MP0001986_abnormal_taste_sensitivity | 3.86484978 |
| 3 | MP0005174_abnormal_tail_pigmentation | 3.57452591 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.55562680 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.22431057 |
| 6 | MP0003436_decreased_susceptibility_to | 3.03948424 |
| 7 | MP0005409_darkened_coat_color | 2.68593605 |
| 8 | MP0003136_yellow_coat_color | 2.66769761 |
| 9 | MP0004381_abnormal_hair_follicle | 2.58173318 |
| 10 | MP0003303_peritoneal_inflammation | 2.57504521 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.44922503 |
| 12 | MP0009840_abnormal_foam_cell | 1.99361112 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 1.96290311 |
| 14 | MP0003329_amyloid_beta_deposits | 1.94040204 |
| 15 | MP0009278_abnormal_bone_marrow | 1.86058336 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.80953663 |
| 17 | MP0005025_abnormal_response_to | 1.78277373 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.76882035 |
| 19 | MP0001790_abnormal_immune_system | 1.70638005 |
| 20 | MP0005387_immune_system_phenotype | 1.70638005 |
| 21 | MP0000015_abnormal_ear_pigmentation | 1.67750189 |
| 22 | MP0000604_amyloidosis | 1.67563361 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.65274379 |
| 24 | MP0001502_abnormal_circadian_rhythm | 1.64912455 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.64724576 |
| 26 | MP0002419_abnormal_innate_immunity | 1.57367302 |
| 27 | MP0002723_abnormal_immune_serum | 1.55502684 |
| 28 | MP0001800_abnormal_humoral_immune | 1.54538692 |
| 29 | MP0000751_myopathy | 1.53868364 |
| 30 | MP0002254_reproductive_system_inflammat | 1.51900180 |
| 31 | MP0004858_abnormal_nervous_system | 1.51317693 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.50880470 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.48417293 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.46827934 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.43201735 |
| 36 | MP0001819_abnormal_immune_cell | 1.42331771 |
| 37 | MP0004947_skin_inflammation | 1.42325417 |
| 38 | MP0001873_stomach_inflammation | 1.41923416 |
| 39 | MP0000685_abnormal_immune_system | 1.38812215 |
| 40 | MP0001958_emphysema | 1.38567406 |
| 41 | MP0006054_spinal_hemorrhage | 1.37564974 |
| 42 | MP0001188_hyperpigmentation | 1.35046571 |
| 43 | MP0005083_abnormal_biliary_tract | 1.31865285 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.31507066 |
| 45 | MP0000750_abnormal_muscle_regeneration | 1.31498854 |
| 46 | MP0005671_abnormal_response_to | 1.31484476 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.29186239 |
| 48 | MP0001756_abnormal_urination | 1.22093664 |
| 49 | MP0002933_joint_inflammation | 1.21205689 |
| 50 | MP0004130_abnormal_muscle_cell | 1.18816178 |
| 51 | MP0000858_altered_metastatic_potential | 1.18140629 |
| 52 | MP0002398_abnormal_bone_marrow | 1.17450215 |
| 53 | MP0006082_CNS_inflammation | 1.17258609 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.16291039 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.16244197 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.16083424 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.15806711 |
| 58 | MP0000716_abnormal_immune_system | 1.15089679 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.10330345 |
| 60 | MP0003279_aneurysm | 1.10253453 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 1.09049174 |
| 62 | MP0003724_increased_susceptibility_to | 1.08404343 |
| 63 | MP0000538_abnormal_urinary_bladder | 1.07923658 |
| 64 | MP0001849_ear_inflammation | 1.07756881 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07542065 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.04628206 |
| 67 | MP0003091_abnormal_cell_migration | 1.03956378 |
| 68 | MP0009785_altered_susceptibility_to | 1.01569033 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.00954537 |
| 70 | MP0008260_abnormal_autophagy | 0.99093011 |
| 71 | MP0002405_respiratory_system_inflammati | 0.98303855 |
| 72 | MP0002429_abnormal_blood_cell | 0.96177105 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.96118108 |
| 74 | MP0000747_muscle_weakness | 0.95989678 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.93619927 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.91690921 |
| 77 | MP0004510_myositis | 0.90785872 |
| 78 | MP0005330_cardiomyopathy | 0.90625322 |
| 79 | MP0002722_abnormal_immune_system | 0.88573903 |
| 80 | MP0008874_decreased_physiological_sensi | 0.87895496 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.87748823 |
| 82 | MP0008469_abnormal_protein_level | 0.83081634 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.82917653 |
| 84 | MP0003879_abnormal_hair_cell | 0.82530598 |
| 85 | MP0003448_altered_tumor_morphology | 0.82339023 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.79304716 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.76657347 |
| 88 | MP0000678_abnormal_parathyroid_gland | 0.76034085 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.75407277 |
| 90 | MP0003866_abnormal_defecation | 0.74401550 |
| 91 | MP0005166_decreased_susceptibility_to | 0.74096671 |
| 92 | MP0004859_abnormal_synaptic_plasticity | 0.73913585 |
| 93 | MP0003075_altered_response_to | 0.73430126 |
| 94 | MP0001664_abnormal_digestion | 0.73006257 |
| 95 | MP0005451_abnormal_body_composition | 0.72049873 |
| 96 | MP0000367_abnormal_coat/_hair | 0.71262333 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.71180421 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.70179322 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69458159 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.69305190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 5.11348951 |
| 2 | Thin bony cortex (HP:0002753) | 5.06700263 |
| 3 | Annular pancreas (HP:0001734) | 5.02908106 |
| 4 | Rib fusion (HP:0000902) | 4.41506169 |
| 5 | Testicular atrophy (HP:0000029) | 4.37774467 |
| 6 | Axonal loss (HP:0003447) | 3.92907172 |
| 7 | Ulnar bowing (HP:0003031) | 3.84418089 |
| 8 | Hemorrhage of the eye (HP:0011885) | 3.84414815 |
| 9 | Turricephaly (HP:0000262) | 3.73627511 |
| 10 | Mesangial abnormality (HP:0001966) | 3.57075534 |
| 11 | Progressive external ophthalmoplegia (HP:0000590) | 3.12182838 |
| 12 | Agnosia (HP:0010524) | 3.11577353 |
| 13 | Joint stiffness (HP:0001387) | 3.07056102 |
| 14 | Intestinal fistula (HP:0100819) | 3.05160779 |
| 15 | Vaginal fistula (HP:0004320) | 3.04036741 |
| 16 | Rectovaginal fistula (HP:0000143) | 2.97636513 |
| 17 | Rectal fistula (HP:0100590) | 2.97636513 |
| 18 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.86667087 |
| 19 | Dysostosis multiplex (HP:0000943) | 2.86412517 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.84855465 |
| 21 | Poikiloderma (HP:0001029) | 2.80402948 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73994206 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73994206 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73994206 |
| 25 | Akinesia (HP:0002304) | 2.73002580 |
| 26 | Nasal polyposis (HP:0100582) | 2.71494052 |
| 27 | Mask-like facies (HP:0000298) | 2.70239105 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.69409986 |
| 29 | Delayed epiphyseal ossification (HP:0002663) | 2.68511322 |
| 30 | Disinhibition (HP:0000734) | 2.68475254 |
| 31 | Facial hemangioma (HP:0000329) | 2.68178475 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.66509931 |
| 33 | Joint hemorrhage (HP:0005261) | 2.65953945 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.65071563 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60012274 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.60012274 |
| 37 | Anteriorly placed anus (HP:0001545) | 2.55730516 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.55121751 |
| 39 | Abnormality of the costochondral junction (HP:0000919) | 2.54437656 |
| 40 | Personality changes (HP:0000751) | 2.52824997 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.52280990 |
| 42 | Upper motor neuron abnormality (HP:0002127) | 2.46178208 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40406248 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.37301126 |
| 45 | Dyschromatopsia (HP:0007641) | 2.36816448 |
| 46 | Bowing of the arm (HP:0006488) | 2.35496103 |
| 47 | Bowed forearm bones (HP:0003956) | 2.35496103 |
| 48 | Facial diplegia (HP:0001349) | 2.25442455 |
| 49 | Colitis (HP:0002583) | 2.24438052 |
| 50 | Squamous cell carcinoma (HP:0002860) | 2.20872452 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.20582190 |
| 52 | Emphysema (HP:0002097) | 2.20274950 |
| 53 | Pustule (HP:0200039) | 2.18642703 |
| 54 | Coronal craniosynostosis (HP:0004440) | 2.18581461 |
| 55 | Enlarged epiphyses (HP:0010580) | 2.17728340 |
| 56 | Increased IgE level (HP:0003212) | 2.16243080 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.14303026 |
| 58 | Myopathic facies (HP:0002058) | 2.14004647 |
| 59 | Easy fatigability (HP:0003388) | 2.13910977 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.13645361 |
| 61 | Popliteal pterygium (HP:0009756) | 2.12041194 |
| 62 | Aplasia of the musculature (HP:0100854) | 2.10305457 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.09560312 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.04426387 |
| 65 | Widely patent fontanelles and sutures (HP:0004492) | 2.04172189 |
| 66 | Choanal stenosis (HP:0000452) | 2.03016163 |
| 67 | External ophthalmoplegia (HP:0000544) | 2.02272398 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.02176610 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.00717363 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.00064627 |
| 71 | Male infertility (HP:0003251) | 1.98187052 |
| 72 | Broad face (HP:0000283) | 1.96373497 |
| 73 | Abnormality of macrophages (HP:0004311) | 1.93420614 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 1.92797976 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91793985 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91781900 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91781900 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91781900 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91683960 |
| 80 | Rapidly progressive (HP:0003678) | 1.90896832 |
| 81 | Mediastinal lymphadenopathy (HP:0100721) | 1.90364718 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 1.88938655 |
| 83 | Short chin (HP:0000331) | 1.88306761 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 1.88027520 |
| 85 | Atrioventricular block (HP:0001678) | 1.87676742 |
| 86 | Hypertriglyceridemia (HP:0002155) | 1.86782064 |
| 87 | Abnormality of the intrinsic pathway (HP:0010989) | 1.86287662 |
| 88 | Myositis (HP:0100614) | 1.83926412 |
| 89 | Ocular albinism (HP:0001107) | 1.83585276 |
| 90 | Recurrent skin infections (HP:0001581) | 1.83329956 |
| 91 | Neonatal onset (HP:0003623) | 1.82526095 |
| 92 | Cervical subluxation (HP:0003308) | 1.81517359 |
| 93 | Meningitis (HP:0001287) | 1.80762203 |
| 94 | Stridor (HP:0010307) | 1.80499953 |
| 95 | Thin ribs (HP:0000883) | 1.79384520 |
| 96 | Malnutrition (HP:0004395) | 1.77320240 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.74853572 |
| 98 | Recurrent sinusitis (HP:0011108) | 1.74030319 |
| 99 | Narrow nasal bridge (HP:0000446) | 1.72720865 |
| 100 | Purpura (HP:0000979) | 1.72574252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.90071446 |
| 2 | TRIB3 | 3.82831404 |
| 3 | MAP4K1 | 2.75798459 |
| 4 | ERN1 | 2.69582274 |
| 5 | SIK1 | 2.35885634 |
| 6 | PRPF4B | 2.25624398 |
| 7 | BLK | 2.19718737 |
| 8 | GRK6 | 1.96802050 |
| 9 | EEF2K | 1.93188800 |
| 10 | SIK2 | 1.78910705 |
| 11 | MAP3K13 | 1.78112033 |
| 12 | TBK1 | 1.77450523 |
| 13 | TESK2 | 1.74964600 |
| 14 | MAP2K3 | 1.58805976 |
| 15 | RIPK4 | 1.58026217 |
| 16 | ICK | 1.57144435 |
| 17 | CSK | 1.53968004 |
| 18 | SMG1 | 1.53783868 |
| 19 | ZAP70 | 1.52287494 |
| 20 | ARAF | 1.50864127 |
| 21 | MAP3K11 | 1.47700806 |
| 22 | TNK2 | 1.43982889 |
| 23 | MAPK12 | 1.38370427 |
| 24 | MARK2 | 1.37401665 |
| 25 | MAP3K1 | 1.37172004 |
| 26 | PRKD2 | 1.36333132 |
| 27 | FGFR4 | 1.32904363 |
| 28 | PKN2 | 1.24303217 |
| 29 | NME2 | 1.23394176 |
| 30 | MUSK | 1.21363623 |
| 31 | RIPK1 | 1.18439625 |
| 32 | PDPK1 | 1.16363760 |
| 33 | TYK2 | 1.14432846 |
| 34 | CDC42BPA | 1.13239412 |
| 35 | SYK | 1.10813247 |
| 36 | BCKDK | 1.10720546 |
| 37 | MAP2K6 | 1.07377202 |
| 38 | IKBKE | 1.05070956 |
| 39 | MAPK11 | 1.05064384 |
| 40 | IRAK3 | 1.01780447 |
| 41 | RPS6KA2 | 1.01249486 |
| 42 | IRAK4 | 1.00577264 |
| 43 | SCYL2 | 0.95953450 |
| 44 | EPHB1 | 0.95371816 |
| 45 | IRAK2 | 0.93540916 |
| 46 | CAMKK1 | 0.92264947 |
| 47 | BTK | 0.91040993 |
| 48 | PRKD3 | 0.89359789 |
| 49 | DAPK2 | 0.85915898 |
| 50 | HIPK2 | 0.80860297 |
| 51 | MAP3K3 | 0.80410012 |
| 52 | TLK1 | 0.80122675 |
| 53 | FES | 0.78141881 |
| 54 | RPS6KC1 | 0.77395888 |
| 55 | RPS6KL1 | 0.77395888 |
| 56 | CDK4 | 0.76883831 |
| 57 | WNK4 | 0.75237135 |
| 58 | DYRK1B | 0.74852166 |
| 59 | JAK3 | 0.72370353 |
| 60 | MAPK7 | 0.72109914 |
| 61 | BMX | 0.71287691 |
| 62 | HCK | 0.70517776 |
| 63 | TAOK1 | 0.70324647 |
| 64 | RPS6KA6 | 0.66769500 |
| 65 | KSR2 | 0.66509594 |
| 66 | MARK3 | 0.66105129 |
| 67 | PDK1 | 0.64658574 |
| 68 | LCK | 0.64551576 |
| 69 | TAOK2 | 0.64502902 |
| 70 | KIT | 0.63138055 |
| 71 | SIK3 | 0.63052260 |
| 72 | MAP3K14 | 0.62627285 |
| 73 | TXK | 0.61144650 |
| 74 | IKBKB | 0.59663691 |
| 75 | SGK223 | 0.58821190 |
| 76 | SGK494 | 0.58821190 |
| 77 | TYRO3 | 0.58349011 |
| 78 | MAPKAPK3 | 0.57716678 |
| 79 | PTK6 | 0.53728542 |
| 80 | MAP2K2 | 0.52924415 |
| 81 | PRKD1 | 0.52381307 |
| 82 | PRKCH | 0.52340822 |
| 83 | PIM2 | 0.52041070 |
| 84 | JAK1 | 0.51206227 |
| 85 | MAP3K10 | 0.50864489 |
| 86 | MTOR | 0.50527636 |
| 87 | MOS | 0.50394234 |
| 88 | TTN | 0.49674486 |
| 89 | LYN | 0.48083484 |
| 90 | CDK11A | 0.45692423 |
| 91 | CDK15 | 0.43963410 |
| 92 | ITK | 0.43609705 |
| 93 | SGK3 | 0.43102689 |
| 94 | RET | 0.42937075 |
| 95 | TESK1 | 0.42309200 |
| 96 | MAP3K7 | 0.41670482 |
| 97 | MAP3K9 | 0.41553270 |
| 98 | PRKCQ | 0.37229797 |
| 99 | MAPK8 | 0.34398007 |
| 100 | CDK18 | 0.34393283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 4.13456457 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.93952608 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.04481867 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.81914465 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.93683745 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91460521 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.78514639 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75546414 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.62969941 |
| 10 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.60841218 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57585371 |
| 12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.56557319 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.54083802 |
| 14 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50625242 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47736348 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47380772 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42754815 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.39193430 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38866110 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38742731 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35905884 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33071185 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32392212 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31383908 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28871018 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28010445 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25288495 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22100468 |
| 29 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.16883865 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.15008041 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11169662 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06176074 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05373990 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04652798 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04169797 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02070177 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.01622938 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98722961 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98617550 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98392243 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97987373 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.94224078 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93231334 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87553968 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86835931 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86622988 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 0.86586016 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86422076 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83742531 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81180521 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77050276 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76759262 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76326397 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75612997 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.74887465 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74528399 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74074331 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71590498 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.71530553 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70921554 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70668115 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66166223 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65842047 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.65576163 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63399726 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.63323581 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62811889 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.62739730 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61087907 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61034343 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60071258 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.58876146 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58170341 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54910778 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54019974 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53437326 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53069156 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.52822923 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52499751 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50444717 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49531763 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49070150 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49044740 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46548416 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.46326523 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45528603 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45478545 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.44314353 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43417299 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43321984 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.42954505 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42928066 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42620157 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41222392 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39889014 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37964814 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37257711 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34160261 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32979353 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32766636 |

